The Nigerian economy has seen the closure of many companies, especially multinational firms, which threw many Nigerians into ...

Nigeria, the giant of Africa, has recently experienced a great downturn in its economy, leading to the exodus of several ...

The Federal Government is advancing its commitment to ensure a self-sustaining healthcare system by collaborating with ...

Minister Pate emphasised that GSK’s investment in localised production represents a crucial milestone in Nigeria’s quest for a robust healthcare system, one that effectively addresses the ...

GSK's generous funding allows Save the Children to respond immediately ... including our biggest programs in the Democratic Republic of Congo, Ethiopia, Kenya, Nigeria and Yemen. Together, we are ...

GSK further contends that Moderna got its hands on technical know-how tied to the company’s mRNA vaccine platform by “hiring several former Novartis and GSK employees with first-hand knowledge.” ...

LONDON — GSK’s once-booming vaccines business met new challenges in the third quarter, as the company lowered sales forecasts for vaccines for the year. Notably, quarterly sales of the ...

Also Read: Just After Pfizer’s RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population Specialty Medicine sales increased ...

"Nigeria's medical device market will grow at a 2023-2028 ... making health insurance mandatory for citizens and legal residents." Listing Sanofi and GlaxoSmithKline as firms that left the country due ...

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.

Welcome to today's call and webcast. The Q3 presentation was sent to our distribution list by e-mail and you can also find it on gsk.com. Please turn to Slide 2. This is the usual safe harbor ...